GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Baxter International Inc. (BAX) [hlAlert]

Rating:
Mkt Outperform
BAX
down 22.33 %

Baxter International Inc. (BAX) rated Mkt Outperform with price target $59 by Avondale

Posted on: Thursday,  May 28, 2009  11:25 AM ET by Avondale

Avondale rated Mkt Outperform Baxter International Inc. (NYSE: BAX) on 05/28/2009, when the stock price was $49.69.
Since then, Baxter International Inc. has lost 22.34% as of 11/16/2015's recent price of $38.59.
If you would have followed this Avondale's recommendation on BAX, you would have lost 22.33% of your investment in 2363 days.

Baxter engages in the worldwide development, manufacture and distribution of a diversified line of products, systems and services used primarily in the health-care field. The company's products are used by hospitals, clinical and medical research laboratories, blood and dialysis centers, rehabilitation centers, nursing homes, doctors' offices and by patients, at home, under physician supervision.

Avondale’s research analysts are charged with producing high quality, independent, value-added, and timely investment analysis / advice. The firm’s strategy is to deemphasize maintenance research, and instead direct the overwhelming majority of our efforts on developing well-constructed, actionable recommendations, in part by leveraging proprietary networks of industry contacts. Avondale’s growing research department now totals 25 professionals. Senior analysts average 14 years of industry experience and are routinely recognized by a variety of nationally known rating entities. In the last two years, Avondale Analysts were named to the Wall Street Journal’s Best on the Street poll as well as Forbes.com’s Top Analyst Rankings.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/28/2009 11:25 AM Buy
None
49.69 59.00
as of 12/31/2009
1 Week down  -15.84 %
1 Month down  -9.27 %
3 Months down  -13.19 %
1 YTD down  -0.40 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy